Patel Chem appoints B R S & Associates as Cost Auditor for FY 2026-27

1 min read     Updated on 22 May 2026, 02:41 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

PATEL CHEM SPECIALITIES LIMITED has appointed M/s B R S & Associates as Cost Auditor for FY 2026-27 effective May 22, 2026, following Board approval to comply with the Companies Act, 2013 and SEBI regulations.

powered bylight_fuzz_icon
40986674

*this image is generated using AI for illustrative purposes only.

PATEL CHEM SPECIALITIES LIMITED has announced the appointment of M/s B R S & Associates as its Cost Auditor for the financial year 2026-27. The decision was taken by the Board of Directors in their meeting held on May 22, 2026, following the recommendation of the Audit Committee.

Appointment Details

The appointment is effective from May 22, 2026. M/s B R S & Associates, a firm with extensive experience in cost audit, cost compliance, cost records review, and cost management advisory services, will oversee the cost audit functions for the company.

Compliance and Reasoning

The move is intended to comply with the provisions of the Companies Act, 2013 and the requirements under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that there are no specific relationships between directors and the appointed firm that require disclosure.

Key Information

Sr.No. Details of Events Information of such event(s)
1. Reason for change Appointment: to comply with the Companies Act, 2013 and the requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
2. Date of appointment & term With effect from May 22, 2026. M/s B R S & ASSOCIATES Appointed as Cost Auditor for the Financial Year 2026-27.
3. Brief profile M/s B R S & ASSOCIATES, is a firm having extensive experience in cost audit, cost compliance, cost records review, and cost management advisory services.
4. Disclosure of relationships NA

The intimation regarding this appointment was submitted to BSE Limited on May 22, 2026, by Bhupesh Patel, Managing Director of the company.

Historical Stock Returns for Patel Chem Specialities

1 Day5 Days1 Month6 Months1 Year5 Years
+2.29%+20.00%-0.02%+5.23%-14.84%-14.84%

How might the findings from M/s B R S & Associates' cost audit influence Patel Chem Specialities' pricing strategy and profit margins for FY 2026-27?

Could the cost audit reveal operational inefficiencies that may lead to significant restructuring or cost-cutting measures within Patel Chem Specialities?

How does Patel Chem Specialities' cost management performance compare to peers in the specialty chemicals sector, and could audit outcomes affect its competitive positioning?

Patel Chem Specialities
View Company Insights
View All News
like15
dislike

Patel Chem FY26 Net Profit Rises 19% to ₹1,255 Lakh

2 min read     Updated on 22 May 2026, 02:32 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Patel Chem Specialities Limited reported a 19% increase in FY26 net profit to ₹1,255.22 lakh, supported by a 30.6% rise in revenue from operations to ₹13,726.33 lakh. Total revenue for the year reached ₹13,908.19 lakh, while total expenses were managed at ₹12,209.91 lakh. The board approved the audited financial results, re-appointed statutory and internal auditors for FY27, and confirmed no deviation in IPO fund utilization.

powered bylight_fuzz_icon
40985313

*this image is generated using AI for illustrative purposes only.

Patel Chem Specialities Limited announced its audited financial results for the year ended March 31, 2026, reporting a significant rise in profitability and operational revenue. The company's net profit for the fiscal year stood at ₹1,255.22 lakh, an increase of 19% compared to ₹1,056.52 lakh in the previous year. This growth was driven by a robust performance in revenue from operations, which climbed to ₹13,726.33 lakh from ₹10,508.78 lakh in FY25.

Financial Performance

The total revenue for FY26 reached ₹13,908.19 lakh, up from ₹10,555.18 lakh in the corresponding period last year. While the cost of raw materials consumed rose to ₹10,177.42 lakh, the company managed its total expenses effectively at ₹12,209.91 lakh. Profit before tax for the year was recorded at ₹1,698.28 lakh, compared to ₹1,409.53 lakh in the prior year. The basic and diluted earnings per share (EPS) improved to ₹6.63 from ₹5.91 in the previous year.

Operational Metrics

The board reviewed and approved the annual audited financial statements alongside the draft auditor's report. The statutory auditors, M/s Parikh Shah & Associates, issued an unmodified opinion on the audited financial results. The company also noted that it does not have more than one reportable segment in terms of AS-17, making segment-wise reporting inapplicable.

Board Decisions

In addition to the financial results, the Board of Directors approved the re-appointment of several auditors for FY 2026-2027. M/s Bimal Shah Associates were re-appointed as Internal Auditors, M/s RTBR & Associates as Secretarial Auditors, and M/s BRS & Associates as Cost Auditors. The board also reviewed related party transactions for the half-year ended March 31, 2026, and took note of the statement of utilization of funds raised through the IPO.

Financial Results Summary

Particulars FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Revenue from Operations 13,726.33 10,508.78
Total Revenue 13,908.19 10,555.18
Total Expenses 12,209.91 9,145.65
Profit Before Tax 1,698.28 1,409.53
Net Profit 1,255.22 1,056.52
EPS (Basic & Diluted) 6.63 5.91

The company confirmed that there was no deviation or variation in the use of proceeds from the objects stated in the prospectus for the half-year ended March 31, 2026. The total funds raised through the IPO amounted to ₹5,880 lakhs, with a significant portion allocated to capital expenditure and general corporate purposes.

Historical Stock Returns for Patel Chem Specialities

1 Day5 Days1 Month6 Months1 Year5 Years
+2.29%+20.00%-0.02%+5.23%-14.84%-14.84%

How will Patel Chem Specialities deploy the remaining IPO proceeds allocated to capital expenditure, and what revenue impact is expected from these investments in FY27?

Given the sharp rise in raw material costs to ₹10,177.42 lakh, what strategies is the company considering to hedge against commodity price volatility and protect margins going forward?

With revenue growing ~31% year-over-year, which specific product segments or geographies are driving this growth, and is this trajectory sustainable in FY27?

Patel Chem Specialities
View Company Insights
View All News
like17
dislike

More News on Patel Chem Specialities

1 Year Returns:-14.84%